Summary

Overview
The Global Peripheral Interventions Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX% during the forecast period 2023-2030.
Peripheral interventions refres to treatments for ailments affecting the body's peripheral vascular system, which consists of arteries and veins outside the heart and brain. Conditions like deep vein thrombosis (DVT), peripheral artery disease (PAD), and other vascular illnesses are frequently treated using these techniques and technologies.
Developments in medical device technologies, such as minimally invasive procedures and improved stent designs, have expanded the range of treatable conditions and made interventions safer and more effective. The growing prevalence of diseases like peripheral artery disease and deep vein thrombosis has contributed to the growth of this market.
Market Dynamics: Drivers
The Increasing Prevalence of Peripheral Artery Disease
According to Life Journal in 2022, The European Region had the highest prevalence of PAD (7.99%), with the age range of 45–54 years old accounting for the majority of the high case numbers. The African region has the lowest prevalence (4.06%). More than two-thirds (68%) of the global prevalence was represented by case counts from fifteen nations, with China, India, and the United States reporting the greatest case numbers.
According to an International organization in 2020, It is estimated that between 41 and 54 million people in India suffer from peripheral artery disease. Between 4.2 and 6.2 million people suffer from critical limb ischemia. Type 2 diabetes, smoking, and hypercholesterolemia are the main causes of PAD because they cause plaque to accumulate in the arteries.
For peripheral artery disease (PAD), the Eluvia Drug-Eluting Stent and the Ranger Drug-Coated Balloon are the first devices supported by level-one randomized controlled trials (RCTs). Boston Scientific provides two drug-eluting PAD options, each supported by comparative efficacy head-to-head trials. Medical professionals select the course of action based on the patient's needs and the lesion.
Regulatory Challenges
Strict legal guidelines and lengthy approval procedures for medical devices might make it more difficult to bring new innovations and goods to market. For particular patient populations, the high cost of some peripheral therapies and related devices may prevent them from being used. Every medical operation carries some risk, and patients may decide not to undergo peripheral interventions due to problems. It's possible that knowledge concerning vascular illnesses and the value of early intervention is still lacking in some areas.
Segment Analysis
The global peripheral interventions market is segmented based on product type, application, end-user and region.
The guide wires segment accounted for approximately 56.7% of the market share
Guidewires are vital instruments in vascular and interventional operations, and they are frequently used in peripheral interventions. Thin, flexible wires called guidewires are used to position catheters, navigate through the circulatory system, and create a pathway for the delivery of various medical supplies or therapies.
Medtronic offers The Wholey guidewire system, which comes in a range of lengths, tip configurations, levels of support, and flexibility, can be used to navigate difficult instances. A uniform coating is applied across the coil thanks to the device's unique precoating technique, which facilitates a more seamless interface with interventional devices.
Selecting Nitrex guidewires will allow you to enjoy remarkable performance in a nitinol guidewire. The highly visible, atraumatic gold tungsten tip of the guidewire combined with its nitinol core makes it easy to navigate complex anatomy and tough lesions. Different tip shapes and styles of Nitrex guidewires are available to match your procedural demands..
Geographical Analysis
North America accounted for approximately 41.4% of the market share
North America has been a dominant force in the global peripheral interventions market. According to the Centers for Disease Control and Prevention (CDC), the disorder known as peripheral arterial disease (PAD) is defined by the constriction or obstruction of the blood arteries that carry blood from the heart to the lower limbs.
About 6.5 million adults over 40 in the US suffer from PAD, which is mostly brought on by atherosclerosis, or the accumulation of fatty plaque in the arteries. Patients who identify as Black or Hispanic may experience PAD at rates that are comparable to or somewhat greater than those of White patients.
The prevalence of PAD varies depending on criteria, as it is common to underestimate the disease burden when only symptomatic patients are included. Adults over 70 years of age have the highest frequency of PAD, with rates rising quickly with age.4. 5 In the US, 1.3% of individuals suffer from severe PAD associated with critical limb ischemia (CLI) or chronic limb-threatening ischemia (CLTI), which can result in amputation.
COVID-19 Impact Analysis
The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global peripheral interventions market. Many non-urgent medical operations, including some peripheral interventions, were postponed or delayed during the early stages of the pandemic in order to conserve healthcare resources and lower the possibility of viral transmission. The number of procedures temporarily decreased as a result of this.
Certain people avoided or delayed obtaining medical attention because to their fear of catching COVID-19 in hospital environments. This may have an effect on the patient pool for peripheral procedures because it was particularly true for less urgent cases.
By Product Type
• Catheters
• Sheath
• Stents
• Guide Wires
• Atherectomy Devices
• Embolic Devices
• Thrombectomy Devices
• IVC Filters
• Others
By Application
• Peripheral Artery Disease
• Venous Thromboembolism
• Others
By End-User
• Hospitals
• Catheterization Laboratories
• Ambulatory Surgical Centres
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Angioscore Ltd., Cordis Corp., Boston Scientific, Cook Medical, Medtronic Inc., Volcano Corporation, Terumo Interventional Systems Inc., Teleflex Medical, Edward Lifesciences among others.
Key Developments
• In September 2021, Abbott acquired Walk Vascular, LLC, a commercial-stage medical device organization with a minimally invasive mechanical aspiration thrombectomy system developed to remove peripheral blood clots.
Why Purchase the Report?
• To visualize the global peripheral interventions market segmentation based on product type, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of peripheral interventions market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global peripheral interventions market report would provide approximately 61 tables, 64 figures, and 186 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The Increasing Prevalence of Peripheral Artery Disease
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. Regulatory Challenges
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. SWOT Analysis
5.7. Patent Analysis
5.8. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Catheters*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Sheath
7.4. Stents
7.5. Guide Wires
7.6. Atherectomy Devices
7.7. Embolic Devices
7.8. Thrombectomy Devices
7.9. IVC Filters
7.10. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Peripheral Artery Disease*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Venous Thromboembolism
8.4. Others
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Catheterization Laboratories*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centres
9.4. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Abbott Vascular*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Angioscore Ltd.
12.3. Cordis Corp.
12.4. Boston Scientific
12.5. Cook Medical
12.6. Medtronic Inc.
12.7. Volcano Corporation
12.8. Terumo Interventional Systems Inc.
12.9. Teleflex Medical
12.10. Edward Lifesciences
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us